Neurogene (NGNE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Neurogene (NGNE) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Neurogene

· NGNE

Dashboard

Financials

Ratios

Valuation

Statistics

568.123 M

-2.01%

General

Market Cap: $568.12M
Enterprise Value: $335.48M
Shares Outstanding: 19,740,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -45.47%
ROE: -45.11%
ROIC: -53.72%
Current Ratio: 10.64
Debt-to-Equity: 0.04
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.27
P/S: —
P/FCF: —
P/B: 2.02
EV/EBITDA: -3.16

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $102.46M
Operating Income: -$121.35M
Net Profit: -$111.11M

Balance Sheet

Cash and Equivalents: $112.49M
Working Capital: $207.41M
Total Assets: $244.36M
Net Debt: -$104.14M
Total Liabilities: $27.23M
Total Equity: $217.13M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$86.24M
Cash Flow from Investing: $104.66M
Cash Flow from Financing: $36.61M
Free Cash Flow: -$87.11M
Capital Expenditures: $875.4K